A Food and Drug Administration–Approved Antiviral Agent that Inhibits Adenylyl Cyclase Type 5 Protects the Ischemic Heart Even When Administered after Reperfusion - Concepedia

Concepedia

Publication | Open Access

A Food and Drug Administration–Approved Antiviral Agent that Inhibits Adenylyl Cyclase Type 5 Protects the Ischemic Heart Even When Administered after Reperfusion

DOI Full Paper Access

22

Citations

29

References

2016

Year

Claudio Bravo, Dorothy E. Vatner, Ronald Pachon, Jie Zhang, S. F. Vatner

Journal of Pharmacology and Experimental Therapeutics

References

	Year	Citations

Page 1